Logotype for Chicago Atlantic Real Estate Finance Inc

Chicago Atlantic Real Estate Finance (REFI) Q4 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Chicago Atlantic Real Estate Finance Inc

Q4 2025 earnings summary

12 Mar, 2026

Executive summary

  • Operates at the intersection of real estate, credit, and the U.S. cannabis sector, focusing on senior secured debt investments with limited lending competition.

  • Closed over $3.2B in loans since inception, with $411.1M in outstanding principal as of December 31, 2025.

  • Maintains a specialized team of over 100 professionals managing $2.3B in capital, leveraging over 100 years of combined expertise and $8B in real estate and commercial credit.

  • Portfolio is diversified by loan size, rate type, operator, geography, and collateral type, with minimal overlap with broader private credit markets.

  • Investment pipeline increased to $616 million, with recent activity including a credit facility for the largest cannabis ESOP to date.

Financial highlights

  • Loan portfolio principal totaled $411.1 million across 26 companies as of December 31, with a weighted average yield to maturity of 16.3%.

  • Net income for 2025 was $36.0 million, compared to $37.0 million in 2024.

  • Distributable earnings for 2025 were $40.4 million, nearly flat year-over-year.

  • Book value per share was $14.60 as of December 31, with 21.5 million shares outstanding.

  • Annualized dividend yield to cost has averaged 12.5% since inception, with $41.4 million in regular dividends declared for 2025.

Outlook and guidance

  • Dividend payout ratio for 2026 expected to be 90%–100% of distributable earnings per diluted share, with potential for a special dividend if required.

  • Regulatory reforms, including federal rescheduling of cannabis and a ban on unregulated hemp-derived THC, are expected to improve revenue visibility and margin durability for licensed operators.

  • Industry revenue projected to grow from $35B in 2025 to $69B by 2031, with an estimated 11%+ annual growth rate.

  • Management anticipates 2026 to be a pivotal year due to potential regulatory changes and strong investment demand.

  • Rescheduling of cannabis has increased demand for debt capital but has not yet affected pricing or underwriting standards.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more